Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × OTHER × Intellectual Disability × Clear all

Phase

Phase NA 10 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 69 Neoplasms 66 Carcinoma, Hepatocellular 45 Prostatic Neoplasms 43 Colorectal Neoplasms 43 Leukemia, Myeloid, Acute 37 Carcinoma, Non-Small-Cell Lung 33 Stomach Neoplasms 32 Precursor Cell Lymphoblastic Leukemia-Lymphoma 30 Neoplasm Metastasis 26 Pancreatic Neoplasms 24 Rectal Neoplasms 20 Multiple Myeloma 20 Lung Neoplasms 20 Hematologic Neoplasms 18 Recurrence 17 Lymphoma 16 Leukemia 15 Colonic Neoplasms 15 Polycystic Ovary Syndrome 14 Esophageal Neoplasms 13 Head and Neck Neoplasms 12 Myelodysplastic Syndromes 11 Motor Activity 11 Fatigue 11 Liver Neoplasms 10 Brain Neoplasms 10 Glioblastoma 9 Esophageal Squamous Cell Carcinoma 9 Depression 9

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01730209 2015-05-05

RAPIT

Erasmus Medical Center

Phase 2/3 Unknown

Autistic Disorder, Intellectual Disability, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡